These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24867421)

  • 41. Design, synthesis and bioevaluation of an EphA2 receptor-based targeted delivery system.
    Barile E; Wang S; Das SK; Noberini R; Dahl R; Stebbins JL; Pasquale EB; Fisher PB; Pellecchia M
    ChemMedChem; 2014 Jul; 9(7):1403-12. PubMed ID: 24677792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and characterization of octreotide-modified curcumin plus docetaxel micelles for potential treatment of non-small-cell lung cancer.
    An Q; Shi CX; Guo H; Xie SM; Yang YY; Liu YN; Liu ZH; Zhou CZ; Niu FJ
    Pharm Dev Technol; 2019 Nov; 24(9):1164-1174. PubMed ID: 31340709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
    Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
    Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and Solutol HS 15.
    Yan HM; Song J; Zhang ZH; Jia XB
    Drug Deliv; 2016 Oct; 23(8):2911-2918. PubMed ID: 26644047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
    Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
    Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.
    Savla R; Garbuzenko OB; Chen S; Rodriguez-Rodriguez L; Minko T
    Pharm Res; 2014 Dec; 31(12):3487-502. PubMed ID: 24919932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer.
    Jin G; Jin M; Jin Z; Gao Z; Yin X
    Oncol Rep; 2016 Aug; 36(2):871-6. PubMed ID: 27279008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
    Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
    Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
    ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel ibuprofen derivative with anti-lung cancer properties: synthesis, formulation, pharmacokinetic and efficacy studies.
    Cheng KW; Nie T; Ouyang N; Alston N; Wong CC; Mattheolabakis G; Papayannis I; Huang L; Rigas B
    Int J Pharm; 2014 Dec; 477(1-2):236-43. PubMed ID: 25311177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.
    Liu J; Liu J; Chu L; Wang Y; Duan Y; Feng L; Yang C; Wang L; Kong D
    Int J Nanomedicine; 2010 Dec; 6():59-69. PubMed ID: 21289982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.
    Shen H; Rodriguez-Aguayo C; Xu R; Gonzalez-Villasana V; Mai J; Huang Y; Zhang G; Guo X; Bai L; Qin G; Deng X; Li Q; Erm DR; Aslan B; Liu X; Sakamoto J; Chavez-Reyes A; Han HD; Sood AK; Ferrari M; Lopez-Berestein G
    Clin Cancer Res; 2013 Apr; 19(7):1806-15. PubMed ID: 23386691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
    Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
    J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydrophobically modified polysaccharide-based on polysialic acid nanoparticles as carriers for anticancer drugs.
    Jung B; Shim MK; Park MJ; Jang EH; Yoon HY; Kim K; Kim JH
    Int J Pharm; 2017 Mar; 520(1-2):111-118. PubMed ID: 28179099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delivery of paeonol by nanoparticles enhances its in vitro and in vivo antitumor effects.
    Chen C; Jia F; Hou Z; Ruan S; Lu Q
    Int J Nanomedicine; 2017; 12():6605-6616. PubMed ID: 28924345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment.
    Bariwal J; Kumar V; Chen H; Bhattarai RS; Peng Y; Li W; Mahato RI
    J Control Release; 2019 Sep; 309():231-243. PubMed ID: 31330213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.
    Wang B; Zhang W; Zhou X; Liu M; Hou X; Cheng Z; Chen D
    Drug Deliv; 2019 Dec; 26(1):1265-1279. PubMed ID: 31777307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.